Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide works by activating both GLP-1 and GIP receptors in your body, making it one of the most potent weight loss medications available. Most people start at a low dose and gradually increase it over weeks until they reach their maintenance level—the dose that delivers consistent results without excessive side effects. Understanding how maintenance dosing works helps set realistic expectations for your treatment journey.

What is a Tirzepatide Maintenance Dose?

A maintenance dose is the amount of tirzepatide your body needs each week to sustain weight loss and appetite suppression without requiring further increases. Unlike a starting dose, which is deliberately low to help your system adjust, a maintenance dose represents stability—the point where you've found the therapeutic sweet spot. Most people reach maintenance between weeks 12 and 20 of treatment, though individual timelines vary based on body composition, metabolism, and metabolic sensitivity.

Maintenance doses typically range between 7.5 mg and 15 mg weekly, though some individuals benefit from staying at 5 mg or going higher under medical supervision. The goal is not necessarily the highest dose, but the dose that produces your desired weight loss with tolerable side effects. PlexusDx providers work with you to identify this personalized target rather than pushing toward a one-size-fits-all endpoint.

The Tirzepatide Titration Timeline and Cost Stability

PlexusDx offers compounded tirzepatide injection starting at $249 per month, and this price remains flat regardless of whether you're starting at 2.5 mg or maintaining at 15 mg. Your dose may need to go up. Your price won't. This transparent pricing model eliminates the financial anxiety many patients experience when escalating to higher therapeutic doses over their first four to five months of treatment.

A typical titration schedule involves weekly injections with increases every 4 weeks: you might start at 2.5 mg, move to 5 mg in week four, then 7.5 mg in week eight, and reach 10 mg or 15 mg by week twelve. During this entire period, your cost stays the same, allowing you to focus on adjustment and results rather than budgeting for climbing expenses. Once you stabilize at your maintenance dose, you'll continue weekly injections with consistent pricing and predictable outcomes.

Genetic Factors That Shape Your Maintenance Dose

Your genetics significantly influence how you respond to tirzepatide and what maintenance dose works best for your body. The GLP1R rs6923761 variant, for example, affects how efficiently your GLP-1 receptors signal appetite suppression, meaning some people feel full effects at lower doses while others need higher amounts. The GIPR rs1800437 variant similarly modulates your response to the GIP component of tirzepatide, influencing both weight loss intensity and gastrointestinal tolerance.

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map 14 metabolic pathways, including these key variants across 49 peptides and 150+ genetic insights. Understanding your genetic predispositions helps your PlexusDx provider anticipate whether you'll respond robustly at 5 mg or need to climb toward 15 mg, personalizing your titration schedule and maintenance target before you even begin. This prevents unnecessary side effects from over-dosing and ensures you're not under-treated because of genetic differences your provider couldn't otherwise predict.

Reaching Maintenance: What to Expect Week to Week

Weeks 1–4 introduce your body to tirzepatide at a low 2.5 mg dose, typically producing mild appetite reduction and nausea as your system adapts. You'll likely notice less hunger at meals and may spontaneously eat smaller portions without feeling deprived. Nausea usually peaks at injection time but fades within 24–48 hours; taking it in the evening and staying hydrated helps minimize discomfort.

Weeks 5–8 bring the first dose increase to 5 mg as your tolerance improves. Appetite suppression strengthens, weight loss accelerates, and nausea often decreases despite the higher dose—a sign your receptors are adjusting. Weeks 9–12 take you to 7.5 or 10 mg, where most people experience dramatic appetite changes and begin seeing consistent weekly weight loss of 1–2 pounds. Weeks 13+ involve reaching your personal maintenance dose, which your PlexusDx provider determines based on your response, side effect tolerance, and weight loss goals rather than a standard protocol.

Managing Side Effects at Your Maintenance Dose

Nausea, constipation, and mild fatigue are the most common side effects during titration, but they often stabilize or improve once you've reached maintenance. If side effects persist at your current dose, your PlexusDx provider may hold you at a lower maintenance level rather than pushing higher—because effective treatment means sustainable treatment. Staying hydrated, eating small protein-rich meals, and taking fiber supplements address the majority of GI concerns without requiring dose reduction.

Some people experience a phenomenon called 'GLP-1 fatigue' during the first month, where energy dips despite losing weight. This typically resolves by week 8–12 as your body adjusts. If it persists at maintenance, your provider may recommend adding B vitamins or adjusting meal timing. The key principle: your maintenance dose should feel sustainable long-term, not like a constant battle against side effects. PlexusDx providers monitor your experience at each tier and adjust your maintenance target accordingly.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long until I reach my maintenance dose of tirzepatide?

Most people reach their target maintenance dose between 12 and 20 weeks of treatment, with increases every 4 weeks starting from 2.5 mg. Your timeline depends on how quickly your body tolerates each dose escalation and whether your provider identifies a therapeutic dose before reaching the maximum. PlexusDx providers customize your pace based on your side effect profile and weight loss response.

Does my PlexusDx price change if my maintenance dose is higher?

No. PlexusDx compounded tirzepatide injection costs $249 per month flat, whether you're at 2.5 mg or 15 mg. Your dose may need to go up. Your price won't. This ensures you can titrate safely without financial barriers limiting your treatment options.

What's the difference between induction and maintenance dosing with tirzepatide?

Induction refers to the titration phase where you gradually increase your dose every 4 weeks to help your body adapt and find your therapeutic level. Maintenance is the stable dose you reach once side effects are tolerable and weight loss is consistent—the dose you'll stay on long-term. Maintenance typically ranges from 7.5 to 15 mg weekly.

Can I stay on a lower tirzepatide maintenance dose if I'm getting results?

Yes. If you're losing weight consistently and feeling good at 5 mg or 7.5 mg, there's no medical reason to increase further. PlexusDx providers prioritize sustainable treatment over reaching a preset maximum dose. Your maintenance dose is personalized to your goals and tolerance, not a one-size-fits-all target.

How does the Precision Peptide Genetic Test help predict my maintenance dose?

The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, and 12 other metabolic pathways that influence how strongly you respond to tirzepatide. If your genetic profile shows robust GLP-1 signaling, you may reach maintenance at a lower dose; weaker signaling might require climbing higher. This genetic roadmap helps your PlexusDx provider anticipate your optimal dose before starting treatment.

Is compounded tirzepatide from PlexusDx safe for long-term maintenance?

Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under FDA oversight and strict quality standards. Compounded tirzepatide has the same active ingredient and efficacy as brand-name Mounjaro, just at a lower cost and without requiring insurance approval.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves